愛爾眼科簡介

分享到:

  愛爾眼科醫院集團是中國及全球范圍醫院規模和醫療能力領先的眼科醫療集團,覆蓋亞洲、歐洲和北美洲,在中國內地、歐洲、東南亞擁有3家上市公司(中國深圳:愛爾眼科,300015;西班牙:CBAV;新加坡:40T),眼科醫院及中心數量達600余家,其中中國內地500余家、中國香港7家、美國1家、歐洲80余家,東南亞12家,中國內地年門診量超1000萬人次。

  AIER Eye Hospital Group is China’s leading ophthalmology hospital group that covers Asia, Europe, and North America with huge scale and outstanding medical capacity. It has three listed companies in China (stock code: 300015) ,Europe (Spain: CBAV), and Southeast Asia (Singapore: 40T) with a total number of more than 600 specialized eye hospitals and centers and the annual outpatient visits in mainland China exceeded 10 million. Among those eye hospitals and centers, there are more than 500 in Mainland China, 7 in Hong Kong, 1 in the United States, more than 80 in Europe, and 12 in Southeast Asia.

  愛爾眼科致力于引進和吸收國際同步的眼科技術與醫療管理理念,以專業化、規模化、科學化為發展戰略,推動中國眼科醫療事業的發展。

  AIER is committed to the parallel introduction and absorption of world-leading ophthalmic technology and management concept, with professionalism, scale and science as its strategy to advance China's ophthalmic medical care.

  通過不斷的探索與實踐,并充分吸納國際先進的醫療管理經驗的基礎上,成功探索出一套適應中國國情和市場環境的眼科醫院連鎖經營管理模式——“分級連鎖”。利用人才、技術和管理等方面的優勢,通過全國各連鎖醫院優良的診療質量、優質的醫療服務和良好的醫患溝通,使愛爾眼科成為全國各地眼科患者信賴的眼科醫院。

  Base on constant exploration and practice, also with absorbing advanced international medical management experience, AIER Eye Hospital Group has successfully established the "hierarchical chain" management model that adapts to China's market environment. Utilizing our advantages in talent, technology and management, we aim to provide the most trusted eye care to patients all over the country by offering good medical quality, superior medical service and harmonious doctors-to-patients communication.

  2013年,愛爾眼科醫院集團與中南大學聯合成立專業的眼科醫學院——中南大學愛爾眼科學院,主要培養眼科碩、博士精英醫療人才,開啟了社會資本參與醫學教育的有益創新和探索;

  2014年,與湖北科技大學聯合成立愛爾眼視光學院,旨在培養眼視光學的專業技術人才。

  2019年,新增武漢大學愛爾眼科臨床學院及研究院。

  與此同時,自2015年愛爾眼科先后成立愛爾眼科研究所、愛爾眼視光研究所、角膜病研究所、白內障研究所、青光眼研究所、視網膜研究所和屈光研究所等7大研究所,旨在推動眼科學、視覺科學以及各亞專科前沿和臨床應用技術的研究和創新。

  愛爾眼科通過成立學院和研究所等機構,正式打通了眼科的醫、學、研三大領域,使愛爾眼科的科研及臨床水平得到顯著提升,并以此推動中國眼科醫療事業的發展和進步。

  In 2013, AIER and Central South University jointly set up AIER School of Ophthalmology, CSU, to educate and train medical professionals with advanced degrees,which opened a new era for social capital to be involved in medical education.

  In 2014, AIER joined the Hubei University of Science and Technology to establish the AIER School of Ophthalmology & Optometry, which aims to cultivate specialized talents in Optometry.

  In 2019, AIER Clinical College of Ophthalmology, and Ophthalmic Research Institute in Wuhan University were found.

  Besides, AIER has established 7 institutes since 2011, they are AIER Ophthalmology Institute, AIER Optometry Institute, AIER Refraction Institute, AIER Corneal Institute, AIER Glaucoma Institute, AIER Retinology Institute, and AIER Cataract Institute.

  At this point, AIER has bridged all three areas of medicine, education, and research, the establishment of these educational and research institutions will significantly boost our research and clinical standards.

  在快速跨越式發展的過程中,愛爾眼科凝聚和培養了一批經驗豐富、開拓創新的管理團隊和醫術精良、治學嚴謹的眼科專家和醫生團隊。截止2020年4月,愛爾眼科集團及旗下全球員工總數 36,000余人,其中眼科及視光醫生總數(含海外)7,400余人,包括一大批碩士生導師、博士生導師、博士、博士后、留學歐美的學者以及臨床經驗豐富的核心專家,是中國眼科領域備受矚目的有生力量。

  In the process of rapid development, AIER has gathered and cultivated a group of experienced and innovative management team and a team of ophthalmologists with excellent medical ability and rigorous academic background. As of April, 2020,AIER has more than 36,000 employees globally, including 7,400 ophthalmologists and optometrists. Ophthalmologists in AIER consist of a large number of Master's supervisor, PH.D supervisor, Ph.D, Post doctorates, scholars trained in Europe and the United States and core experts with rich clinical experience. They are a high-profile core force in the field of ophthalmology in China.

  愛爾眼科的發展壯大,始終以“使所有人,無論貧窮富裕,都享有眼健康的權利”為使命,追求社會責任和自身發展的和諧統一,通過開創性的“交叉補貼”模式,一方面為患者提供更高品質的眼科醫療服務,同時全面開展防盲治盲工作、投身社會公益和幫助弱勢群體,并聯合社會各界,推動整個中國防盲事業乃至國民眼健康事業的全面發展。

  Since its founding, AIER always committed to the mission,“Enabling everyone, whether rich or poor, has the right to eye health.”With its "cross-subsidy" model, AIER provides patients with higher quality services, in the meantime dedicate itself to the social welfare and helping vulnerable groups to promote the cause of fighting blindness and national eye health.

  隨著中國醫療衛生體制改革的進一步推進,愛爾眼科順應國家醫療衛生政策和發展趨勢,適時在醫療行業推出“合伙人計劃”,致力于改變眼科醫生執業的生態環境,最大限度地激發核心骨干的創造力和能動性,為推動公司規模與效益的同步提高注入持續發展的關鍵動力。愛爾眼科專注于眼科醫療服務事業,將在全國的城鄉縣域興建各級專業連鎖眼科醫院,為更多的人提供高質量、多層次的眼科醫療服務。

  With the reform on China's medical health system, AIER adapts to the national medical policy and trend, launching the "Partnership Program" in the healthcare industry to focus on changing the ecological environment for ophthalmologists and maximizing the creativity and initiative of core members in 2014. This strategy is a strong motivation for expanding AIER’s scale, raising benefits. AIER has always been focusing on eye care service and will establish more professional hospitals in smaller cities and counties providing high quality and multi-level eye care to more people.


微信訂閱愛爾眼科
請關注公眾號:aierhospital ,愛眼護眼早知道。
重庆幸运农场开奖走势图百度